Compile Data Set for Download or QSAR
Report error Found 18 Enz. Inhib. hit(s) with all data for entry = 917
TargetProlyl endopeptidase(Human)
Universitat De Barcelona

US Patent
LigandPNGBDBM298372(US10125097, Example 20 | (S)-1-((S)-1-(4-(benzylox...)
Affinity DataIC50: 4.5nMAssay Description:POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
Go to US Patent

TargetProlyl endopeptidase(Human)
Universitat De Barcelona

US Patent
LigandPNGBDBM298373(US10125097, Example 21 | (S)-1-((S)-1-(4-(benzylox...)
Affinity DataIC50: 5nMAssay Description:POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
Go to US Patent

TargetProlyl endopeptidase(Human)
Universitat De Barcelona

US Patent
LigandPNGBDBM298357(US10125097, Example 6 | (S)-1-((2S,4S)-1-(4-(benzy...)
Affinity DataIC50: 13.1nMAssay Description:POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
Go to US Patent

TargetProlyl endopeptidase(Human)
Universitat De Barcelona

US Patent
LigandPNGBDBM298355(US10125097, Example 4 | (S)-1-((2S)-1-(4-(benzylox...)
Affinity DataIC50: 48.7nMAssay Description:POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
Go to US Patent

TargetProlyl endopeptidase(Human)
Universitat De Barcelona

US Patent
LigandPNGBDBM298352(US10125097, Example 2 | (S)-1-((2S,4R)-1-(4-(benzy...)
Affinity DataIC50: 60.4nMAssay Description:POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
Go to US Patent

TargetProlyl endopeptidase(Human)
Universitat De Barcelona

US Patent
LigandPNGBDBM298345(US10125097, Example 1 | (S)-1-((2S,4R)-1-(4-(benzy...)
Affinity DataIC50: 63.8nMAssay Description:POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
Go to US Patent

TargetProlyl endopeptidase(Human)
Universitat De Barcelona

US Patent
LigandPNGBDBM298363(US10125097, Example 12 | (S)-1-((2S)-1-(4-benzoylo...)
Affinity DataIC50: 111nMAssay Description:POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
Go to US Patent

TargetProlyl endopeptidase(Human)
Universitat De Barcelona

US Patent
LigandPNGBDBM298356(US10125097, Example 5 | (S)-1-((2S,4S)-1-(4-(benzy...)
Affinity DataIC50: 176nMAssay Description:POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
Go to US Patent

TargetProlyl endopeptidase(Human)
Universitat De Barcelona

US Patent
LigandPNGBDBM298359(US10125097, Example 8 | (S)-1-((2S,4S)-1-(4-(benzy...)
Affinity DataIC50: 176nMAssay Description:POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
Go to US Patent

TargetProlyl endopeptidase(Human)
Universitat De Barcelona

US Patent
LigandPNGBDBM298371(US10125097, Example 19 | (S)-1-((S)-1-(2-(benzylox...)
Affinity DataIC50: 255nMAssay Description:POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
Go to US Patent

TargetProlyl endopeptidase(Human)
Universitat De Barcelona

US Patent
LigandPNGBDBM298368(US10125097, Example 17 | (S)-1-((S)-1-(4-(benzylox...)
Affinity DataIC50: 287nMAssay Description:POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
Go to US Patent

TargetProlyl endopeptidase(Human)
Universitat De Barcelona

US Patent
LigandPNGBDBM298364(US10125097, Example 13 | (S)-1-((2S)-1-(3,4-dibenz...)
Affinity DataIC50: 336nMAssay Description:POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
Go to US Patent

TargetProlyl endopeptidase(Human)
Universitat De Barcelona

US Patent
LigandPNGBDBM298353(US10125097, Example 3 | (S)-1-((2S,4S)-1-(4-(benzy...)
Affinity DataIC50: 339nMAssay Description:POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
Go to US Patent

TargetProlyl endopeptidase(Human)
Universitat De Barcelona

US Patent
LigandPNGBDBM298361(US10125097, Example 11 | (S)-1-((2S)-1-(4-acetoxy-...)
Affinity DataIC50: 352nMAssay Description:POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
Go to US Patent

TargetProlyl endopeptidase(Human)
Universitat De Barcelona

US Patent
LigandPNGBDBM298369(US10125097, Example 18 | (S)-1-((S)-1-(3-(benzylox...)
Affinity DataIC50: 487nMAssay Description:POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
Go to US Patent

TargetProlyl endopeptidase(Human)
Universitat De Barcelona

US Patent
LigandPNGBDBM298360(US10125097, Example 9 | (S)-1-((2S,4R)-1-(4-(benzy...)
Affinity DataIC50: 668nMAssay Description:POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
Go to US Patent

TargetProlyl endopeptidase(Human)
Universitat De Barcelona

US Patent
LigandPNGBDBM298367(US10125097, Example 16 | (S)-1-((2S)-1-(3-pivaloyl...)
Affinity DataIC50: 2.14E+3nMAssay Description:POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
Go to US Patent

TargetProlyl endopeptidase(Human)
Universitat De Barcelona

US Patent
LigandPNGBDBM298366(US10125097, Example 15 | (S)-1-((2S)-1-(3-acetoxy-...)
Affinity DataIC50: 5.60E+3nMAssay Description:POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
Go to US Patent